STADA has a local sales company in the United Kingdom:
Genus Pharmaceuticals Ltd. in Newburry.
In United Kingdom sales increased by 5% to EUR 13.3 million (1-3/2011: EUR 12.7 million) – applying the exchange rates of the previous year sales increased by 1% – primarily attributable to the development of the two branded products ApoGo®1) and Cetraben®2) as well as a positive currency effect of the pound sterling.
| 1) | Active ingredient apomorphine for the treatment of Parkinson‘s disease. |
| 2) | Treatment series for the treatment of skin eczema and dry skin. |
| 1) | Sales below EUR 0.05 million were rounded to EUR 0.0 million. |